-
Italy bans Novartis vaccines even after company assures their safetyItaly is having a difficult time getting flu vaccine. Italian authorities today said they are banning four different Novartis ($NVS) vaccines because of questions over "side effects" less than two wee2012/10/25
-
BMS results crater on 96% drop in Plavix salesBristol-Myers Squibb's ($BMY) third quarter continues the generics-are-poison trend. The company saw sales drop by 30%--yes, 30%--as copycats siphoned off sales from its big-selling blood-pressure dru2012/10/25
-
'Slight decline' in pharmaceutical M&A activityThe last 18 months has seen a slight decline in pharmaceutical merger and acquisition (M&A) activity, following steady levels since 2008, a report has revealed.Research by intelligence firm Irving2012/10/24
-
Ashland unveils optimised portfolio of tablet film coating systemsAshland Specialty Ingredients has introduced an optimised range of functional tablet coatings following its recent acquisition of International Specialty Products (ISP). The company's range of Aquari2012/10/24
-
Medicated chewing gum may prevent motion sicknessScientists in Iran have managed to overcome the unpleasant taste of the drug dimenhydrinate and developed a novel medicated chewing gum that could help to treat motion sickness. The team wanted to in2012/10/23
-
Report reveals large untapped market for rheumatoid arthritis drugsThe emergence of anti-tumour necrosis factor (anti-TNF) therapies has vastly improved the treatment of rheumatoid arthritis in recent years, but there is still a need for more effective therapies, a r2012/10/23
-
China’s Leading DDS & formulation Event is Coming Back With Brand-new Highlights!Following the huge success of NDDS China 2011, CPhI will host 2nd NDDS China 2012 on 22-24, October in Shanghai, China. Novel drug delivery is one of the fastest growing pharmaceutical sectors. The th2012/10/22
-
GSK wins Canadian tax case over transfer pricingGlaxoSmithKline ($GSK) prevailed in a tax challenge from the Canadian government. The U.K.-based drugmaker won backing from the country's highest court, in a much-watched battle over using transfer pr2012/10/22
-
Thermogelled capsules made from excipient Hypromellose perform in studyA new study has shown that plant-based capsules made from an excipient called Hypromellose (HPMC) have a faster and more predictable dissolution profile when manufactured using a thermal gelling proce2012/10/19
-
Avantor and Rubicon to collaborate on novel gastro-retentive excipientAvantor Performance Materials has signed a collaborative agreement with Rubicon Research which should lead to the development of a new gastro-retentive excipient. Mumbai-based Rubicon is recognised a2012/10/19